Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 559 Records) |
Query Trace: Neoplasms and PALB2[original query] |
---|
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study. Breast cancer research : BCR 2023 12 25 (1): 152. Han-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, Chih-Yi Hsu, Pei-Ju Lien, Yen-Shu Lin, Ta-Chung Chao, Jiun-I Lai, Chin-Jung Feng, Yen-Jen Chen, Bo-Fang Chen, Jen-Hwey Chiu, Ling-Ming Tseng, Chi-Cheng Hua |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene. Genetics in medicine : official journal of the American College of Medical Genetics 2024 8 101230. Robert D Morgan, George J Burghel, Nicola Flaum, Helene Schlecht, Andrew R Clamp, Jurjees Hasan, Claire Mitchell, Zena Salih, Sarah Moon, Martin Hogg, Rosemary Lord, Claire Forde, Fiona Lalloo, Emma R Woodward, Emma J Crosbie, Stephen S Taylor, Gordon C Jayson, D Gareth R Eva |
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. JCO precision oncology 2024 8 8 e2400014. Laura S Graham, Nicholas C Henderson, Olesia Kellezi, Clara Hwang, Pedro C Barata, Mehmet A Bilen, Deepak Kilari, Michael Pierro, Bicky Thapa, Abhishek Tripathi, George Mo, Matthew Labriola, Joseph J Park, Shoshana Rothstein, Rohan Garje, Vadim S Koshkin, Vaibhav G Patel, Tanya Dorff, Andrew J Armstrong, Rana R McKay, Ajjai Alva, Michael T Schweiz |
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer. World journal of urology 2024 8 42 (1): 491. Moritz Hommerding, Oliver Hommerding, Marit Bernhardt, Tobias Kreft, Christine Sanders, Verena Tischler, Patrick Basitta, Natalie Pelusi, Anna-Lena Wulf, Carsten-Henning Ohlmann, Jörg Ellinger, Manuel Ritter, Glen Kristians |
The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024). Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2024 8 38 (4): 292-299. P Kleiblová, J Novotný, D Cibula, V Curtisová, O Dubová, L Foretová, A Germanová, M Janatová, O Havránek, M Hojsáková, M Hudcová, M Koudová, V Krutílková, M Palacova, S Paulich, K Petrakova, J Presl, A Puchmajerová, J Soukupová, M Šenke?íková, Z Šimková, H Št?pánková, I Šubrt, I Tachecí, P Tesner, O Urban, K Veselá, Š Vilímová, Z Vl?ková, M Vo?ka, V Weinberger, M Zikán, M Zimovjanová, Z Klei |
A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer. Cancer medicine 2024 8 13 (16): e70103. Jana Soukupova, Barbora Stastna, Madiha Kanwal, Jan Hojny, Petra Zemankova, Marianna Borecka, Leona Cerna, Marta Cerna, Monika Cerna, Vaclava Curtisova, Tatana Dolezalova, Petra Duskova, Lenka Foretova, Ondrej Havranek, Klara Horackova, Milena Hovhannisyan, Lucie Hruskova, Stepan Chvojka, Marketa Janatova, Maria Janikova, Sandra Jelinkova, Pavel Just, Marta Kalousova, Petra Kleiblova, Marcela Kosarova, Monika Koudova, Jan Kral, Michaela Krausova, Vera Krutilkova, Eva Machackova, Katerina Matejkova, Renata Michalovska, Petr Nehasil, Barbora Nemcova, Jan Novotny, Matous Palek, Pavel Pesek, Marketa Safarikova, Ondrej Scheinost, Drahomira Springer, Lenka Stolarova, Viktor Stranecky, Ivan Subrt, Spiros Tavandzis, Eva Tureckova, Kamila Vesela, Zdenka Vlckova, Michal Vocka, Tomas Zima, Libor Macurek, Zdenek Kleibl, |
Double Heterozygosity for Germline Mutations in Chinese Breast Cancer Patients. Cancers 2024 7 16 (14): . Ava Kwong, Cecilia Y S Ho, Chun-Hang Au, Edmond S K |
Genomic profiling and comparative analysis of male versus female metastatic breast cancer across subtypes. Breast cancer research : BCR 2024 7 26 (1): 118. Arun Kadamkulam Syriac, Nitish Singh Nandu, Allison Clark, Mehrad Tavallai, Dexter X Jin, Ethan Sokol, Kimberly McGregor, Jeffrey S Ross, Natalie Danziger, Jose Pablo Leo |
Unraveling the Role of BRCA1 variants in Dysregulation of Transcriptional and Post-Transcriptional Mechanisms in Breast Cancer. Pakistan journal of medical sciences 2024 7 40 (6): 1093-1098. Ayesha Isani Majeed, Sawdah Zinan, Rani Fary |
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients. European journal of cancer (Oxford, England : 1990) 2024 7 208 114226. Giulia Orsi, Catia Carconi, Paola Ghiorzo, Paola Carrera, Lorenza Pastorino, Silvia Presi, Marta Chiaravalli, Elena Barbieri, Guido Giordano, Stefania Sciallero, Alberto Puccini, Lisa Salvatore, Laura Cortesi, Marina Macchini, Maria Iole Natalicchio, Eleonora Allavena, Chiara Pirrone, Livia Archibugi, Bruna Dalmasso, William Bruno, Giampaolo Tortora, Matteo Landriscina, Gabriele Capurso, Stefano Cascinu, Massimo Falconi, Michele Re |
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing. Annals of oncology : official journal of the European Society for Medical Oncology 2024 7 . C F Rowlands, S Allen, J Balmaña, S M Domchek, D G Evans, H Hanson, N Hoogerbrugge, P A James, K Nathanson, M Robson, M Tischkowitz, W D Foulkes, C Turnbu |
BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 2024 6 12 (6): . Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heim |
Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China. Journal of cancer research and clinical oncology 2024 6 150 (6): 322. Jing Li, Peng He, Qindong Cai, Lili Chen, Yali Wang, Weifeng Cai, Yibin Qiu, Shunyi Liu, Wenhui Guo, Minyan Chen, Yuxiang Lin, Chuan Wang, Fangmeng |
Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult-type ovarian granulosa cell tumors. Cancer medicine 2024 6 13 (12): e7340. Rebekah M Summey, Erica Gornstein, Brennan Decker, Kali C Dougherty, Janet S Rader, Elizabeth Ho |
Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. NPJ precision oncology 2024 6 8 (1): 136. Miguel Ruiz-De La Cruz, Héctor Martínez-Gregorio, Clara Estela Díaz-Velásquez, Fernando Ambriz-Barrera, Norma Gabriela Resendiz-Flores, Rina Gitler-Weingarten, María Patricia Rojo-Castillo, Didier Pradda, Javier Oliver, Sandra Perdomo, Eva María Gómez-García, Aldo Hugo De La Cruz-Montoya, Luis Ignacio Terrazas, Gabriela Torres-Mejía, Fidel de la Cruz Hernández-Hernández, Felipe Vaca-Paniag |
Germline mutations of breast cancer susceptibility genes through expanded genetic analysis in unselected Colombian patients. Human genomics 2024 6 18 (1): 68. Diana Carolina Sierra-Díaz, Adrien Morel, Dora Janeth Fonseca-Mendoza, Nora Contreras Bravo, Nicolas Molano-Gonzalez, Mariana Borras, Isabel Munevar, Mauricio Lema, Henry Idrobo, Daniela Trujillo, Norma Serrano, Ana Isabel Orduz, Diego Lopera, Jaime González, Gustavo Rojas, Paula Londono-De Los Ríos, Ray Manneh, Rodrigo Cabrera, Wilson Rubiano, Jairo de la Peña, María Catalina Quintero, William Mantilla, Carlos M Restre |
Identification of RAD17 as a candidate cancer predisposition gene in families with histories of pancreatic and breast cancers. BMC cancer 2024 6 24 (1): 723. Sofie Joris, Philippe Giron, Catharina Olsen, Sara Seneca, Alexander Gheldof, Shula Staessens, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Erik Teugels, Jacques De Grève, Frederik J H |
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2. JCO precision oncology 2024 6 8 e2300494. Erica S Tsang, Mallika S Dhawan, Romain Pacaud, Scott Thomas, Jennifer Grabowsky, Lauren Wilch, Silpa Karipineni, Robin Kate Kelley, Andrew H Ko, Eric Collisson, Jocelyn S Chapman, Stefanie Ueda, Emily K Bergsland, Pamela Munst |
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Cancer 2024 5 . Eve Karloski, Beth Dudley, Brenda Diergaarde, Amie Blanco, Jessica N Everett, Elana Levinson, Tara Rangarajan, Peter P Stanich, Kimberly Childers, Sandra Brown, Christine Drogan, Giulia Martina Cavestro, Kelly Gordon, Aparajita Singh, Diane M Simeone, Hannah Reich, Fay Kastrinos, Dana Zakalik, Heather Hampel, Rachel Pearlman, Ora K Gordon, Sonia S Kupfer, Marta Puzzono, Raffaella Alessia Zuppardo, Randall E Bra |
Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers. JCO precision oncology 2024 5 8 e2400101. Yohei Ando, Mohamad Dbouk, Takeichi Yoshida, Elizabeth Abou Diwan, Helena Saba, Ali Dbouk, Kanako Yoshida, Nicholas J Roberts, Alison P Klein, Richard Burkhart, Jin He, Ralph H Hruban, Michael Goggi |
The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study. Cancers 2024 5 16 (9): . Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Chela, Ebubekir Daglil |
Meta-analysis of breast cancer risk for individuals with PALB2 pathogenic variants. Genetic epidemiology 2024 4 . Thanthirige L M Ruberu, Danielle Braun, Giovanni Parmigiani, Swati Bisw |
Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk. DNA and cell biology 2024 4 . Ying Wang, Yalan Sun, Mingjuan Tan, Xin Lin, Ping Tai, Xiaoqin Huang, Qing Jin, Dan Yuan, Tao Xu, Bangshun |
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. medRxiv : the preprint server for health sciences 2024 4 . Ed M Dicks, Jonthan P Tyrer, Suzana Ezquina, Michelle Jones, John Baierl, Pei-Chen Peng, Michael Diaz, Ellen Goode, Stacey J Winham, Thilo Dörk, Toon Van Gorp, Ana De Fazio, David Bowtell, Kunle Odunsi, Kirsten Moysich, Marina Pavanello, Ian Campbell, James D Brenton, Susan J Ramus, Simon A Gayther, Paul D P Pharo |
Real-world evaluation of deep learning algorithms to classify functional pathogenic germline variants. medRxiv : the preprint server for health sciences 2024 4 . Ryan D Chow, Ravi B Parikh, Katherine L Nathans |
Genetic contribution of breast cancer genes in women of black African origin. Frontiers in genetics 2024 1 14 1302645. Rokhaya Ndiaye, Jean Pascal Demba Diop, Ahmadou Dem, Alioune Die |
Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology 2024 1 . Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Siro |
Genetic predisposition to differentiated thyroid cancer among Polish population. Polish archives of internal medicine 2024 1 . Martyna Borowczyk, Mateusz Sypniewski, Joanna Szyda, Ma?gorzata Braszka, Katarzyna Ziemnicka, Marek Rucha?a, Michalina Oszywa, Zbigniew J Król, Paula Dobo |
BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review. International medical case reports journal 2024 1 17 23-29. Yang Liu, Hui Yang, Xueshu Fu, Luting Zhong, Ping Xu, Fang Fang, Ying Liu, Qing Li, Ya'nan Yan, Shanchuang Wei, Junqing Wang, Chunhua Zha |
- Page last reviewed:Feb 1, 2024
- Content source: